Asia-Pacific Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 27, 2026 Report Code: GDME21841CRDB-ST

Select Item

GlobalData’s “Asia-Pacific Orthobiologics Outlook to 2033” is a comprehensive databook report, covering key market data on the Asia-Pacific Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

The Asia-Pacific Orthobiologics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Orthobiologics Market.
• Global corporate-level profiles of key companies operating within the Asia-Pacific Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Orthobiologics is segmented as follows:

• Cartilage Repair

• Bone Grafts and Substitutes

• Bone Growth Stimulators

• Soft Tissue Biologics

• Viscosupplementation

Reasons to Buy

The Asia-Pacific Orthobiologics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Sanofi
Medtronic Plc
Stryker Corp
Zimmer Biomet Holdings Inc
Seikagaku Corp
Bioventus Inc
Arthrex Inc
Smith & Nephew Plc
Orthofix Holdings Inc
Orthofix Medical Inc
Ferring Pharmaceuticals AS
LifeNet Health Inc
Enovis Corp
Globus Medical Inc
Fidia farmaceutici SpA
AlloSource
CONMED Corp
DePuy Synthes Inc
Xtant Medical Holdings Inc
Anika Therapeutics Inc
Highridge Inc
Avanos Medical Inc

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Orthobiologics Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, Asia-Pacific

3.1 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2018-2033

3.2 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2018-2033

3.3 Orthobiologics Market, Asia-Pacific, Volume (Units), 2018-2033

3.4 Orthobiologics Market, Asia-Pacific, Volume (Units), 2018-2033

3.5 Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), 2025

4 Orthobiologics Market, Australia

4.1 Orthobiologics Market, Australia, Revenue ($m), 2018-2033

4.1.1 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2018-2033

4.1.2 Bone Growth Stimulators Market, Australia, Revenue ($m), by Segment, 2018-2033

4.1.3 Cartilage Repair Market, Australia, Revenue ($m), by Segment, 2018-2033

4.1.4 Soft Tissue Biologics Market, Australia, Revenue ($m), by Segment, 2018-2033

4.1.5 Viscosupplementation Market, Australia, Revenue ($m), by Segment, 2018-2033

4.2 Orthobiologics Market, Australia, Volume (Units), 2018-2033

4.2.1 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2018-2033

4.2.2 Bone Growth Stimulators Market, Australia, Volume (Units), by Segment, 2018-2033

4.2.3 Cartilage Repair Market, Australia, Volume (Units), by Segment, 2018-2033

4.2.4 Soft Tissue Biologics Market, Australia, Volume (Units), by Segment, 2018-2033

4.2.5 Viscosupplementation Market, Australia, Volume (Units), by Segment, 2018-2033

4.3 Orthobiologics Market, Australia, Average Price ($), 2018-2033

4.4 Orthobiologics Market, Australia, Company Share by Revenue ($m), 2025

5 Orthobiologics Market, China

5.1 Orthobiologics Market, China, Revenue ($m), 2018-2033

5.1.1 Bone Grafts and Substitutes Market, China, Revenue ($m), by Segment, 2018-2033

5.1.2 Bone Growth Stimulators Market, China, Revenue ($m), by Segment, 2018-2033

5.1.3 Cartilage Repair Market, China, Revenue ($m), by Segment, 2018-2033

5.1.4 Soft Tissue Biologics Market, China, Revenue ($m), by Segment, 2018-2033

5.1.5 Viscosupplementation Market, China, Revenue ($m), by Segment, 2018-2033

5.2 Orthobiologics Market, China, Volume (Units), 2018-2033

5.2.1 Bone Grafts and Substitutes Market, China, Volume (Units), by Segment, 2018-2033

5.2.2 Bone Growth Stimulators Market, China, Volume (Units), by Segment, 2018-2033

5.2.3 Cartilage Repair Market, China, Volume (Units), by Segment, 2018-2033

5.2.4 Soft Tissue Biologics Market, China, Volume (Units), by Segment, 2018-2033

5.2.5 Viscosupplementation Market, China, Volume (Units), by Segment, 2018-2033

5.3 Orthobiologics Market, China, Average Price ($), 2018-2033

5.4 Orthobiologics Market, China, Company Share by Revenue ($m), 2025

6 Orthobiologics Market, India

6.1 Orthobiologics Market, India, Revenue ($m), 2018-2033

6.1.1 Bone Grafts and Substitutes Market, India, Revenue ($m), by Segment, 2018-2033

6.1.2 Bone Growth Stimulators Market, India, Revenue ($m), by Segment, 2018-2033

6.1.3 Cartilage Repair Market, India, Revenue ($m), by Segment, 2018-2033

6.1.4 Soft Tissue Biologics Market, India, Revenue ($m), by Segment, 2018-2033

6.1.5 Viscosupplementation Market, India, Revenue ($m), by Segment, 2018-2033

6.2 Orthobiologics Market, India, Volume (Units), 2018-2033

6.2.1 Bone Grafts and Substitutes Market, India, Volume (Units), by Segment, 2018-2033

6.2.2 Bone Growth Stimulators Market, India, Volume (Units), by Segment, 2018-2033

6.2.3 Cartilage Repair Market, India, Volume (Units), by Segment, 2018-2033

6.2.4 Soft Tissue Biologics Market, India, Volume (Units), by Segment, 2018-2033

6.2.5 Viscosupplementation Market, India, Volume (Units), by Segment, 2018-2033

6.3 Orthobiologics Market, India, Average Price ($), 2018-2033

6.4 Orthobiologics Market, India, Company Share by Revenue ($m), 2025

7 Orthobiologics Market, Japan

7.1 Orthobiologics Market, Japan, Revenue ($m), 2018-2033

7.1.1 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2018-2033

7.1.2 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2018-2033

7.1.3 Cartilage Repair Market, Japan, Revenue ($m), by Segment, 2018-2033

7.1.4 Soft Tissue Biologics Market, Japan, Revenue ($m), by Segment, 2018-2033

7.1.5 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2018-2033

7.2 Orthobiologics Market, Japan, Volume (Units), 2018-2033

7.2.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2018-2033

7.2.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2018-2033

7.2.3 Cartilage Repair Market, Japan, Volume (Units), by Segment, 2018-2033

7.2.4 Soft Tissue Biologics Market, Japan, Volume (Units), by Segment, 2018-2033

7.2.5 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2018-2033

7.3 Orthobiologics Market, Japan, Average Price ($), 2018-2033

7.4 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2025

8 Orthobiologics Market, South Korea

8.1 Orthobiologics Market, South Korea, Revenue ($m), 2018-2033

8.1.1 Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2018-2033

8.1.2 Bone Growth Stimulators Market, South Korea, Revenue ($m), by Segment, 2018-2033

8.1.3 Cartilage Repair Market, South Korea, Revenue ($m), by Segment, 2018-2033

8.1.4 Soft Tissue Biologics Market, South Korea, Revenue ($m), by Segment, 2018-2033

8.1.5 Viscosupplementation Market, South Korea, Revenue ($m), by Segment, 2018-2033

8.2 Orthobiologics Market, South Korea, Volume (Units), 2018-2033

8.2.1 Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2018-2033

8.2.2 Bone Growth Stimulators Market, South Korea, Volume (Units), by Segment, 2018-2033

8.2.3 Cartilage Repair Market, South Korea, Volume (Units), by Segment, 2018-2033

8.2.4 Soft Tissue Biologics Market, South Korea, Volume (Units), by Segment, 2018-2033

8.2.5 Viscosupplementation Market, South Korea, Volume (Units), by Segment, 2018-2033

8.3 Orthobiologics Market, South Korea, Average Price ($) , 2018-2033

8.4 Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2025

9 Overview of Key Companies in Asia-Pacific Orthobiologics Market

9.1 Sanofi

9.1.1 Company Overview

9.2 Medtronic Plc

9.2.1 Company Overview

9.3 Stryker Corp

9.3.1 Company Overview

9.4 Zimmer Biomet Holdings Inc

9.4.1 Company Overview

9.5 Seikagaku Corp

9.5.1 Company Overview

9.6 Bioventus Inc

9.6.1 Company Overview

9.7 Arthrex Inc

9.7.1 Company Overview

9.8 Smith & Nephew Plc

9.8.1 Company Overview

9.9 Orthofix Holdings Inc

9.9.1 Company Overview

9.10 Orthofix Medical Inc

9.10.1 Company Overview

9.11 Ferring Pharmaceuticals AS

9.11.1 Company Overview

9.12 LifeNet Health Inc

9.12.1 Company Overview

9.13 Enovis Corp

9.13.1 Company Overview

9.14 Globus Medical Inc

9.14.1 Company Overview

9.15 Fidia farmaceutici SpA

9.15.1 Company Overview

9.16 AlloSource

9.16.1 Company Overview

9.17 CONMED Corp

9.17.1 Company Overview

9.18 DePuy Synthes Inc

9.18.1 Company Overview

9.19 Xtant Medical Holdings Inc

9.19.1 Company Overview

9.20 Anika Therapeutics Inc

9.20.1 Company Overview

9.21 Highridge Inc

9.21.1 Company Overview

9.22 Avanos Medical Inc

9.22.1 Company Overview

10 Orthobiologics Market Pipeline Products

11 Recent Developments

11.1 Corporate Communications

11.1.1 Nov 15, 2025: [COA2025] Aikang Medical Excels on Day Two with Six Events Highlighting Global Orthopedic Expertise

11.1.2 Nov 10, 2025: CoreTissue BioEngineering Raises ¥600 Million in New Funding

11.1.3 Nov 06, 2025: Understanding PRP: Biology, Dose and Outcomes in Regenerative Medicine

11.1.4 Oct 29, 2025: Regenerative Medicine Also Known As Stem Cell Therapy

11.1.5 Sep 22, 2025: Arktus Therapeutics Raises 660 Million Yen in Series A and Begins Preclinical Trials for IPS Cartilage

11.2 Financial Announcements

11.2.1 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel

11.3 Government and Public Interest

11.3.1 Sep 05, 2025: 107th Meeting of the Economic Council of CIS Held in Dushanbe

11.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract

11.4 Legal And Regulatory

11.4.1 Apr 15, 2025: Hangzhou SHINING3D Dental Technology Receives 510(K) Clearance For DT20 Denture Base Resin

11.5 Other Significant Developments

11.5.1 Oct 21, 2025: Mochida Pharmaceutical Signs Business Partnership Agreement With Auspicious

11.6 Product News

11.6.1 Nov 13, 2025: Curiteva Announces Publication of Peer-Reviewed Study in Journal of Biomaterials

11.6.2 Nov 03, 2025: EmeTerm Wristband Reduces Postoperative Nausea and Vomiting in Orthopedic Surgeries

11.6.3 Oct 28, 2025: Zimmer Biomet Receives FDA Breakthrough Designation for Iodine-Treated Total Hip Replacement System

11.6.4 Oct 06, 2025: I2Pure Celebrates Zimmer Biomet's Approval of Iodine-Treated Implant System

11.6.5 Oct 01, 2025: Orthocell Appoints First Distributor For Remplir In Canadian Market

11.6.6 Sep 25, 2025: Zimmer Biomet Receives Japan PMDA Approval for Iodine-Treated Total Hip Replacement System

11.6.7 Sep 22, 2025: Arktus Therapeutics Raises 660 Million Yen in Series A and Begins Preclinical Trials for IPS Cartilage

11.6.8 Sep 18, 2025: Brainlab Secures FDA 510(k) Clearance and Launches Spine Mixed Reality Navigation

11.6.9 Sep 17, 2025: First Touch CMC 1 Prosthesis Implanted in the United States

11.6.10 Apr 23, 2025: Assure Tech Receives CLIA Approval for Healcare Panel Dip Test

11.7 Strategy And Business Planning

11.7.1 Nov 10, 2025: CoreTissue BioEngineering Raises ¥600 Million in New Funding

11.7.2 Oct 21, 2025: Mochida Pharmaceutical Signs Business Partnership Agreement With Auspicious

11.7.3 Oct 20, 2025: Mbi And Tci Gene Collaborate On Joint Health Solutions

11.7.4 Oct 01, 2025: Orthocell Appoints First Distributor For Remplir In Canadian Market

11.7.5 Sep 29, 2025: RMTG Partners With BKFC As Official Regenerative Medicine Provider

11.7.6 Sep 17, 2025: Keensight Capital Acquires Majority Stake in Isto Biologics from Thompson Street Capital Partners

12 Appendix

12.1 Research Methodology

12.1.1 Coverage

12.1.2 Secondary Research

12.1.3 Primary Research

12.1.4 Market Modeling and Forecasting

12.1.5 Company Share Analysis

12.1.6 Benchmarking

12.2 GlobalData Consulting

12.3 Contact Us

12.4 Disclaimer

Table

Table 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Table 2: Orthobiologics Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Table 3: Orthobiologics Market, Asia-Pacific, Volume (Units), 2018-2033

Table 4: Orthobiologics Market, Asia-Pacific, Volume (Units), 2018-2033

Table 5: Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), 2025

Table 6: Orthobiologics Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 7: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 8: Bone Growth Stimulators Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 9: Cartilage Repair Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 10: Soft Tissue Biologics Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 11: Viscosupplementation Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 12: Orthobiologics Market, Australia, Volume (Units), 2018-2033

Table 13: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2018-2033

Table 14: Bone Growth Stimulators Market, Australia, Volume (Units), 2018-2033

Table 15: Cartilage Repair Market, Australia, Volume (Units), 2018-2033

Table 16: Soft Tissue Biologics Market, Australia, Volume (Units), 2018-2033

Table 17: Viscosupplementation Market, Australia, Volume (Units), 2018-2033

Table 18: Orthobiologics Market, Australia, Average Price ($), 2018-2033

Table 19: Orthobiologics Market, Australia, Company Share by Revenue ($m), 2025

Table 20: Orthobiologics Market, China, Revenue ($m), USD Constant, 2018-2033

Table 21: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, 2018-2033

Table 22: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, 2018-2033

Table 23: Cartilage Repair Market, China, Revenue ($m), USD Constant, 2018-2033

Table 24: Soft Tissue Biologics Market, China, Revenue ($m), USD Constant, 2018-2033

Table 25: Viscosupplementation Market, China, Revenue ($m), USD Constant, 2018-2033

Table 26: Orthobiologics Market, China, Volume (Units), 2018-2033

Table 27: Bone Grafts and Substitutes Market, China, Volume (Units), 2018-2033

Table 28: Bone Growth Stimulators Market, China, Volume (Units), 2018-2033

Table 29: Cartilage Repair Market, China, Volume (Units), 2018-2033

Table 30: Soft Tissue Biologics Market, China, Volume (Units), 2018-2033

Table 31: Viscosupplementation Market, China, Volume (Units), 2018-2033

Table 32: Orthobiologics Market, China, Average Price ($), 2018-2033

Table 33: Orthobiologics Market, China, Company Share by Revenue ($m), 2025

Table 34: Orthobiologics Market, India, Revenue ($m), USD Constant, 2018-2033

Table 35: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, 2018-2033

Table 36: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, 2018-2033

Table 37: Cartilage Repair Market, India, Revenue ($m), USD Constant, 2018-2033

Table 38: Soft Tissue Biologics Market, India, Revenue ($m), USD Constant, 2018-2033

Table 39: Viscosupplementation Market, India, Revenue ($m), USD Constant, 2018-2033

Table 40: Orthobiologics Market, India, Volume (Units), 2018-2033

Table 41: Bone Grafts and Substitutes Market, India, Volume (Units), 2018-2033

Table 42: Bone Growth Stimulators Market, India, Volume (Units), 2018-2033

Table 43: Cartilage Repair Market, India, Volume (Units), 2018-2033

Table 44: Soft Tissue Biologics Market, India, Volume (Units), 2018-2033

Table 45: Viscosupplementation Market, India, Volume (Units), 2018-2033

Table 46: Orthobiologics Market, India, Average Price ($), 2018-2033

Table 47: Orthobiologics Market, India, Company Share by Revenue ($m), 2025

Table 48: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 49: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 50: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 51: Cartilage Repair Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 52: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 53: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 54: Orthobiologics Market, Japan, Volume (Units), 2018-2033

Table 55: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2018-2033

Table 56: Bone Growth Stimulators Market, Japan, Volume (Units), 2018-2033

Table 57: Cartilage Repair Market, Japan, Volume (Units), 2018-2033

Table 58: Soft Tissue Biologics Market, Japan, Volume (Units), 2018-2033

Table 59: Viscosupplementation Market, Japan, Volume (Units), 2018-2033

Table 60: Orthobiologics Market, Japan, Average Price ($), 2018-2033

Table 61: Orthobiologics Market, Japan, Company Share by Revenue ($m), 2025

Table 62: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 63: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 64: Bone Growth Stimulators Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 65: Cartilage Repair Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 66: Soft Tissue Biologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 67: Viscosupplementation Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 68: Orthobiologics Market, South Korea, Volume (Units), 2018-2033

Table 69: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2018-2033

Table 70: Bone Growth Stimulators Market, South Korea, Volume (Units), 2018-2033

Table 71: Cartilage Repair Market, South Korea, Volume (Units), 2018-2033

Table 72: Soft Tissue Biologics Market, South Korea, Volume (Units), 2018-2033

Table 73: Viscosupplementation Market, South Korea, Volume (Units), 2018-2033

Table 74: Orthobiologics Market, South Korea, Average Price ($), 2018-2033

Table 75: Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2025

Table 76: Orthobiologics Market Pipeline Products

Table 77: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

Figures

Figure 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Figure 2: Orthobiologics Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Figure 3: Orthobiologics Market, Asia-Pacific, Volume (Units), 2018-2033

Figure 4: Orthobiologics Market, Asia-Pacific, Volume (Units), 2018-2033

Figure 5: Orthobiologics Market, Asia-Pacific, Company Share (%), 2025

Figure 6: Orthobiologics Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 7: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 8: Bone Growth Stimulators Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 9: Cartilage Repair Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 10: Soft Tissue Biologics Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 11: Viscosupplementation Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 12: Orthobiologics Market, Australia, Volume (Units), 2018-2033

Figure 13: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2018-2033

Figure 14: Bone Growth Stimulators Market, Australia, Volume (Units), 2018-2033

Figure 15: Cartilage Repair Market, Australia, Volume (Units), 2018-2033

Figure 16: Soft Tissue Biologics Market, Australia, Volume (Units), 2018-2033

Figure 17: Viscosupplementation Market, Australia, Volume (Units), 2018-2033

Figure 18: Orthobiologics Market, Australia, Company Share (%), 2025

Figure 19: Orthobiologics Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 20: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 21: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 22: Cartilage Repair Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 23: Soft Tissue Biologics Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 24: Viscosupplementation Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 25: Orthobiologics Market, China, Volume (Units), 2018-2033

Figure 26: Bone Grafts and Substitutes Market, China, Volume (Units), 2018-2033

Figure 27: Bone Growth Stimulators Market, China, Volume (Units), 2018-2033

Figure 28: Cartilage Repair Market, China, Volume (Units), 2018-2033

Figure 29: Soft Tissue Biologics Market, China, Volume (Units), 2018-2033

Figure 30: Viscosupplementation Market, China, Volume (Units), 2018-2033

Figure 31: Orthobiologics Market, China, Company Share (%), 2025

Figure 32: Orthobiologics Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 33: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 34: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 35: Cartilage Repair Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 36: Soft Tissue Biologics Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 37: Viscosupplementation Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 38: Orthobiologics Market, India, Volume (Units), 2018-2033

Figure 39: Bone Grafts and Substitutes Market, India, Volume (Units), 2018-2033

Figure 40: Bone Growth Stimulators Market, India, Volume (Units), 2018-2033

Figure 41: Cartilage Repair Market, India, Volume (Units), 2018-2033

Figure 42: Soft Tissue Biologics Market, India, Volume (Units), 2018-2033

Figure 43: Viscosupplementation Market, India, Volume (Units), 2018-2033

Figure 44: Orthobiologics Market, India, Company Share (%), 2025

Figure 45: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 46: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 47: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 48: Cartilage Repair Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 49: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 50: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 51: Orthobiologics Market, Japan, Volume (Units), 2018-2033

Figure 52: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2018-2033

Figure 53: Bone Growth Stimulators Market, Japan, Volume (Units), 2018-2033

Figure 54: Cartilage Repair Market, Japan, Volume (Units), 2018-2033

Figure 55: Soft Tissue Biologics Market, Japan, Volume (Units), 2018-2033

Figure 56: Viscosupplementation Market, Japan, Volume (Units), 2018-2033

Figure 57: Orthobiologics Market, Japan, Company Share (%), 2025

Figure 58: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 59: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 60: Bone Growth Stimulators Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 61: Cartilage Repair Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 62: Soft Tissue Biologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 63: Viscosupplementation Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 64: Orthobiologics Market, South Korea, Volume (Units), 2018-2033

Figure 65: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2018-2033

Figure 66: Bone Growth Stimulators Market, South Korea, Volume (Units), 2018-2033

Figure 67: Cartilage Repair Market, South Korea, Volume (Units), 2018-2033

Figure 68: Soft Tissue Biologics Market, South Korea, Volume (Units), 2018-2033

Figure 69: Viscosupplementation Market, South Korea, Volume (Units), 2018-2033

Figure 70: Orthobiologics Market, South Korea, Company Share (%), 2025

Asia-Pacific Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Orthopedic Devices reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation in real time.

  • Access a live Asia-Pacific Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more